41 Results for "Kathleen Mullane"
Kathleen Mullane, DO, PharmD
Clinical Professor of Medicine
Kathleen Mullane, DO, PharmD
Clinical Professor of Medicine
Specialties
Areas of Expertise
- Immunocompromised Patients | More
Locations
What immunocompromised patients should know about the COVID-19 vaccines
Published Thu 2/18/21
The mRNA COVID-19 vaccines are safe for people with compromised immune systems, but they should discuss timing of the shots with their physician.
What is an mRNA vaccine?
Published Wed 4/21/21
In 2020, an mRNA vaccine platform was approved for mass use for the first time to help combat the COVID-19 pandemic. Infectious disease expert Kathleen Mullane, DO, PharmD, has helped lead the Moderna vaccine clinical trial at the University of Chicago Medicine, and she’s here to share some information about how the mRNA vaccine platform works, and how we know it’s safe.
No racial disparities seen in response to remdesivir treatment of COVID-19
Published Fri 7/31/20
New data from UChicago Medicine shows similar improvement across all racial groups and demonstrates the importance of rapid, comprehensive care.
What do we know about COVID virus variants?
Published Thu 12/30/21
What is a variant? How dangerous is it? Infectious diseases experts explain what we currently know about variants of SARS-CoV-2, the virus that causes COVID-19.
Kathleen Drinan, DO
Clinical Associate of Medicine
Kathleen Drinan, DO
Clinical Associate of Medicine
Specialties
Areas of Expertise
- Hypertension
- Vascular Disease
- Women’s Cardiovascular Diseases | More
Locations
Kathleen M. Wiest, MD
Clinical Instructor of Medicine
Lowering LDL cholesterol to reduce heart risk
Published Fri 8/6/21
A good way to prevent heart attacks, strokes and cardiovascular disease is to manage your cholesterol. Cardiologist Kathleen Drinan, DO, who leads the Lipid Clinic at UChicago Medicine, explains why this is important.
Kathleen Beavis, MD
Professor of Pathology
UChicago Medicine launches registry for COVID-19 vaccine trials
Published Tue 9/15/20
Academic health system is recruiting participants for phase 3 studies